+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biotechnology And Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report By Services (Consulting, Auditing & Assessment), By End-use (Pharma, Biotech), By Region, And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 133 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 5505273
Description Jump to:
The global biotechnology and pharmaceutical services outsourcing market size is expected to reach USD 107.96 billion by 2030, according to this report. The market is expected to grow at a CAGR of 5.3% from 2023 to 2030. The COVID-19 pandemic has significantly impacted biotechnology and pharmaceutical third-party service providers as well as clinical trials, resulting in trial delays, suspensions, and terminations. The recovery from the pandemic has led to the increasing adoption of Machine Learning (ML)-based platforms, Artificial Intelligence (AI), automation in drug manufacturing, and innovative trial designs that are projected to transform the CRO and CMO landscape in the coming years.

With rising competitiveness, companies are concentrating on their core capabilities to maximize resources and foster innovation. Focus on their key competencies, such as the development and discovery of new medicines, by outsourcing non-core functions. As a result, several pharmaceutical companies collaborate with various outsourcing service providers for new drug development. For instance, in January 2022, HaemaLogiX, a developer of monoclonal antibodies entered into a partnership with Lonza to manufacture a myeloma drug candidate, KappaMab monoclonal antibody. Biopharmaceutical and pharmaceutical investments in novel and innovative therapies, for instance, regenerative medicine, are driving the R&D activity together with drug development services.

The high demand for biologics along with small molecules has led to the expansion of service portfolios of Contract Manufacturing Organizations (CMOs)/Contract Research Organizations (CROs) for biotechnology and pharmaceutical production. Small pharma/biotech companies are facing challenges while performing in-house development, manufacturing, regulatory affairs, product maintenance, product design, and development, product testing and validation, and training and education, such as a lack of substantial expertise and expensive capability. This, in turn, has created lucrative opportunities for the growth of CMOs and CROs. Contract services are growing and becoming strategic, targeted, and planned.

These factors are expected to play a pivotal role in enhancing the share of CMOs/CROs in the overall market. Growing pricing pressure, regulatory challenges, and patent expiration have led to shrinking margins in the biotech and pharmaceutical industry. Contract services are considered a “strategic competitive weapon” among companies, as these services help overcome these issues. These services offer cost savings to their clients as choosing sustainable suppliers could lead to reduced costs in the long run. They also help save time utilized in the operations and management of a production and research facility. Contract research and manufacturing allow low-cost product development and the manufacturing cost of a product.

Furthermore, outsourcing services assist in overcoming trade barriers and facilitate the entry of firms into the foreign market. Owing to these advantages, several firms choose to outsource services rather than invest capital in production equipment and hiring skilled labor. Furthermore, several key entities in the market are undertaking various strategic initiatives, such as partnerships, service launches, mergers, and acquisitions, to expand their services in the market. For instance, in April 2022, LabCorp, the parent company of Covance, collaborated with a developer of cell and gene therapy technologies, Xcell Biosciences, to expand its research capabilities in cell and gene therapies. Under this agreement, Labcorp and Xcellbio would collaborate on projects aimed at improving the efficacy & safety of cell and gene therapies.

Biotechnology And Pharmaceutical Services Outsourcing Market Report Highlights

  • The consulting segment is expected to dominate the market with a share of 19.6% in 2022 owing to a rise in the number of fraudulent cases, discrepancies in intellectual property rights, and a rise in technological innovations
  • Based on service, the others segment is expected to witness the highest CAGR of 5.3% over the forecast period owing to the increasing focus on generic and biosimilar in developing regions
  • The pharma segment is expected to witness a CAGR of 5.5% over the forecast period as the pharmaceutical companies outsource internal activities at a larger scale due to rising pricing pressure, and growth of generics in the industry
  • On the other hand, the biotechnology segment held a significant share of the market. This is due to the expanding biotech product pipelines
  • North America dominated the market and accounted for the largest revenue share of 53.5% in 2022 due to the presence of a large number of biotechnology and pharmaceutical companies and the quality of services offered by the CROs and CMOs in the region
  • In Asia Pacific, the market is anticipated to register the highest CAGR of 5.8% over the forecast period owing to improved regulatory frameworks, high scope for cost savings, and the presence of cheap skilled personnel
  • The key players in the market undertaking several strategic initiatives to strengthen their market presence. For instance, in February 2023, Elektrofi, a biotech company specializing in advanced drug delivery solutions, entered into a contract manufacturing agreement with Thermo Fisher Scientific. This collaboration will leverage Thermo Fisher Scientific’s expertise in contract manufacturing services to support Elektrofi's drug delivery technology


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.2.1. Information Procurement
1.3. Information or Data Analysis
1.4. Methodology
1.5. Research Scope and Assumptions
1.6. Market Formulation & Validation
1.6.1.1. Country Market: CARG Calculation
1.7. Country Based Segment Share Calculation
1.8. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional Insights
2.4. Competitive Insights
2.5. Biotechnology and Pharmaceutical Services Outsourcing Market Snapshot
2.6. Biotechnology and Pharmaceutical Services Outsourcing Market Segment Snapshot
2.7. Biotechnology and Pharmaceutical Services Outsourcing Market Competitive Landscape Snapshot
Chapter 3. Biotechnology and Pharmaceutical Services Outsourcing Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing outsourcing of R&D activities
3.2.1.2. Changing regulatory landscape
3.2.1.3. Increasing focus on core competencies by pharmaceutical and biotechnology companies
3.2.1.4. Growing drug development costs coupled with high clinical development failure rates
3.2.1.5. Increasing mergers and collaborations
3.2.2. Market Restraint Analysis
3.2.2.1. Monitoring issues and lack of standardization
3.2.2.2. Loss of control
3.2.2.3. Data security issues
3.3. Biotechnology and Pharmaceutical Services Outsourcing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.3. End-use Perception Analysis
3.3.3.1. Why do you outsource Biotechnology and Pharmaceutical services to CROs?
3.3.3.2. Percentage of outsourcing of different services.
3.3.3.3. Importance of CRO selection parameters (Ranking from 1 to 5, where 1 - least important and 5 - most important).
3.3.4. Service Price Analysis
3.3.4.1. Pricing strategy
3.3.4.1.1. Transactional business models
3.3.4.1.2. Performance-based business models
3.3.4.1.3. Outcome-based business models
3.3.4.2. Consulting rates
3.3.4.3. Heat map for pricing analysis
Chapter 4. Biotechnology and Pharmaceutical Services Outsourcing Market: Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Biotechnology and Pharmaceutical Services Outsourcing Market: Service Movement Analysis, USD Million, 2022 & 2030
4.3. Consulting
4.3.1. Consulting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Regulatory Compliance
4.3.2.1. Regulatory Compliance Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Remediation
4.3.3.1. Remediation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Quality Management Systems Consulting
4.3.4.1. Quality Management Systems Consulting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Others
4.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Auditing and Assessment
4.4.1. Auditing and Assessment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Regulatory affairs
4.5.1. Regulatory affairs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Clinical Trial Applications & Product Registration
4.5.2.1. Clinical Trial Applications & Product Registration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Remediation
4.5.3.1. Remediation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Regulatory Writing & Publishing
4.5.4.1. Regulatory Writing & Publishing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.5. Others
4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Product Maintenance
4.6.1. Product Maintenance Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Product Design & Development
4.7.1. Product Design & Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Product Testing & Validation
4.8.1. Product Testing & Validation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Training & Education
4.9.1. Training & Education Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.10. Others
4.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Biotechnology and Pharmaceutical Services Outsourcing Market: End-Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Biotechnology and Pharmaceutical Services Outsourcing Market: End-Use Movement Analysis, USD Million, 2022 & 2030
5.3. Pharmaceutical Companies
5.3.1. Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Biotech Companies
5.4.1. Biotech Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Biotechnology and Pharmaceutical Services Outsourcing Market: Regional Estimates & Trend Analysis
6.1. Biotechnology and Pharmaceutical Services Outsourcing Market: Regional Movement Analysis, 2022 & 2030
6.2. North America
6.2.1. Regulatory Framework
6.2.2. North America Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.3. U.S.
6.2.3.1. Key Country Dynamics
6.2.3.2. Competitive Scenario
6.2.3.3. U.S. Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.4. Canada
6.2.4.1. Key Country Dynamics
6.2.4.2. Competitive Scenario
6.2.4.3. Canada Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Regulatory Framework
6.3.2. Europe Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.3. UK
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. UK Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.4. Germany
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Germany Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.5. France
6.3.5.1. Key Country Dynamics
6.3.5.2. Competitive Scenario
6.3.5.3. Prevalence Insights
6.3.5.4. France Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.6. Italy
6.3.6.1. Key Country Dynamics
6.3.6.2. Competitive Scenario
6.3.6.3. Prevalence Insights
6.3.6.4. Italy Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.7. Spain
6.3.7.1. Key Country Dynamics
6.3.7.2. Competitive Scenario
6.3.7.3. Prevalence Insights
6.3.7.4. Spain Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.8. Denmark
6.3.8.1. Key Country Dynamics
6.3.8.2. Competitive Scenario
6.3.8.3. Prevalence Insights
6.3.8.4. Denmark Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.9. Sweden
6.3.9.1. Key Country Dynamics
6.3.9.2. Competitive Scenario
6.3.9.3. Prevalence Insights
6.3.9.4. Sweden Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.10. Norway
6.3.10.1. Key Country Dynamics
6.3.10.2. Competitive Scenario
6.3.10.3. Prevalence Insights
6.3.10.4. Norway Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Regulatory Framework
6.4.2. Asia Pacific Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.3. Japan
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Prevalence Insights
6.4.3.4. Japan Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.4. China
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Prevalence Insights
6.4.4.4. China Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.5. India
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Prevalence Insights
6.4.5.4. India Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.6. Australia
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Prevalence Insights
6.4.6.4. Australia Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Prevalence Insights
6.4.7.4. Thailand Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.8. South Korea
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Prevalence Insights
6.4.8.4. South Korea Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Regulatory Framework
6.5.2. Latin America Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.3. Brazil
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Brazil Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Mexico Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.5. Argentina
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Argentina Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East & Africa
6.6.1. Regulatory Framework
6.6.2. Middle East & Africa Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.3. South Africa
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. South Africa Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.4. Saudi Arabia
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Saudi Arabia Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.5. UAE
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. UAE Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.6. Kuwait
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Kuwait Biotechnology and Pharmaceutical Services Outsourcing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Company Market Share Analysis, 2022
7.3. Strategy Mapping
7.4. Company Profiles/Listing
7.4.1. The Quantic Group
7.4.1.1. Overview
7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. IQVIA HOLDINGS, INC.
7.4.2.1. Overview
7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Parexel International Corporation
7.4.3.1. Overview
7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Lachman Consultant Services
7.4.4.1. Overview
7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. GMP Pharmaceuticals
7.4.5.1. Overview
7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Concept Heidelberg GmbH
7.4.6.1. Overview
7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Covance, INC.
7.4.7.1. Overview
7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Charles River
7.4.8.1. Overview
7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. PRA Health Sciences
7.4.9.1. Overview
7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. ICON plc.
7.4.10.1. Overview
7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
List of Tables
Table 1: List of secondary sources
Table 2: List of abbreviations
Table 3: Global Biotechnology and Pharmaceutical Services Outsourcing Market, By Region, 2018-2030 (USD Million)
Table 4: Global Biotechnology and Pharmaceutical Services Outsourcing Market, By Services, 2018-2030 (USD Million)
Table 5: Global Biotechnology and Pharmaceutical Services Outsourcing Market, By End Use, 2018-2030 (USD Million)
Table 6: North America Biotechnology and Pharmaceutical Services Outsourcing Market, By Country, 2018-2030 (USD Million)
Table 7: North America Biotechnology and Pharmaceutical Services Outsourcing Market, By Services, 2018-2030 (USD Million)
Table 8: North America Biotechnology and Pharmaceutical Services Outsourcing Market, By End Use, 2018-2030 (USD Million)
Table 9: U.S. Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 10: U.S. Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 11: Canada Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 12: Canada Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 13: Europe Biotechnology and Pharmaceutical Services Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 14: Europe Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 15: Europe Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 16: UK Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 17: UK Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 18: Germany Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 19: Germany Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 20: France Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 21: France Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 22: Italy Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 23: Italy Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 24: Spain Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 25: Spain Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 26: Denmark Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 27: Denmark Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 28: Sweden Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 29: Sweden Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 30: Norway Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 31: Norway Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 32: Asia Pacific Biotechnology and Pharmaceutical Services Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 33: Asia Pacific Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 34: Asia Pacific Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 35: Japan Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 36: Japan Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 37: China Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 38: China Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 39: India Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 40: India Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 41: Australia Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 42: Australia Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 43: Thailand Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 44: Thailand Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 45: South Korea Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 46: South Korea Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 47: Latin America Biotechnology and Pharmaceutical Services Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 48: Latin America Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 49: Latin America Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 50: Brazil Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 51: Brazil Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 52: Mexico Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 53: Mexico Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 54: Argentina Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 55: Argentina Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 56: MEA Biotechnology and Pharmaceutical Services Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 57: MEA Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 58: MEA Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 59: South Africa Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 60: South Africa Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 61: South Arabia Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 62: South Arabia Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 63: UAE Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 64: UAE Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 65: Kuwait Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018-2030 (USD Million)
Table 66: Kuwait Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018-2030 (USD Million)
Table 67: Participant’s overview
Table 68: Financial performance
Table 69: Key companies undergoing expansions
Table 70: Key companies undergoing acquisitions
Table 71: Key companies undergoing collaborations
Table 72: Key companies launching new products/services
Table 73: Key companies undergoing partnerships
Table 74: Key companies undertaking other strategies
List of Figures
Fig. 1: Market segmentation
Fig. 2: Market research process
Fig. 3: Data triangulation techniques
Fig. 4: Primary research pattern
Fig. 5: Market research approaches
Fig. 6: Value-chain-based sizing & forecasting
Fig. 7: QFD modeling for market share assessment
Fig. 8: Market formulation and validation
Fig. 9: Commodity flow analysis
Fig. 10: Biotechnology and Pharmaceutical Services Outsourcing Market Outlook, 2018-2030 (USD Million)
Fig. 11: Biotechnology and Pharmaceutical Services Outsourcing Market Summary, 2021 (USD Million)
Fig. 12: Market trends & outlook
Fig. 13: Parent Market Outlook
Fig. 14: Ancillary Market Outlook
Fig. 15: Market driver analysis (Current & future impact)
Fig. 16: Market restraint analysis (Current & future impact)
Fig. 17: Company market position analysis
Fig. 18: Biotechnology and Pharmaceutical Services Outsourcing market, service outlook key takeaways (USD Million)
Fig. 19: Biotechnology and Pharmaceutical Services Outsourcing market: Service movement analysis (USD Million)
Fig. 20: Consulting market, 2018-2030 (USD Million)
Fig. 21: Regulatory compliance market, 2018-2030 (USD Million)
Fig. 22: Remediation market, 2018-2030 (USD Million)
Fig. 23: Quality management systems market, 2018-2030 (USD Million)
Fig. 24: Other consulting market, 2018-2030 (USD Million)
Fig. 25: Auditing and assessment market, 2018-2030 (USD Million)
Fig. 26: Regulatory affairs market, 2018-2030 (USD Million)
Fig. 27: Clinical trial applications & product registration market, 2018-2030 (USD Million)
Fig. 28: Regulatory writing & publishing market, 2018-2030 (USD Million)
Fig. 29: Legal representation market, 2018-2030 (USD Million)
Fig. 30: Other regulatory affairs market, 2018-2030 (USD Million)
Fig. 31: Product maintenance market, 2018-2030 (USD Million)
Fig. 32: Product design & development market, 2018-2030 (USD Million)
Fig. 33: Product testing & validation market, 2018-2030 (USD Million)
Fig. 34: Training & education market, 2018-2030 (USD Million)
Fig. 35: Others market, 2018-2030 (USD Million)
Fig. 36: Biotechnology and pharmaceutical services outsourcing market: End Use movement analysis
Fig. 37: Biotechnology and pharmaceutical services outsourcing market End Use outlook: Key takeaways
Fig. 38: Pharma market, 2018-2030 (USD Million)
Fig. 39: Biotech market, 2018-2030 (USD Million)
Fig. 40: Regional outlook, 2018 & 2030
Fig. 41: Regional market dashboard
Fig. 42: Regional market place: Key takeaways
Fig. 43: North America biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 44: U.S. biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 45: Canada biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 46: Europe biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 47: UK biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 48: Germany biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 49: France biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 50: Italy biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 51: Spain biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 52: Denmark biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 53: Sweden biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 54: Norway biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 55: Asia Pacific biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 56: Japan biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 57: China (Mainland) biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 58: India biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 59: Australia biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 60: Thailand biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 61: South Korea biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 62: Latin America biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 63: Brazil biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 64: Mexico biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 65: Argentina biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 66: MEA biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 67: South Africa biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 68: Saudi Arabia biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 69: UAE biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)
Fig. 70: Kuwait biotechnology and pharmaceutical services outsourcing market, 2018-2030 (USD Million)

Companies Mentioned

  • The Quantic Group
  • IQVIA HOLDINGS, INC.
  • Parexel International Corporation
  • Lachman Consultant Services
  • GMP Pharmaceuticals
  • Concept Heidelberg GmbH
  • Covance, INC.
  • Charles River
  • PRA Health Sciences
  • ICON plc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages133
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 70.48 Billion
Forecasted Market Value ( USD ) by 2030 $ 107.96 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Biotechnology & Pharmaceutical Services Outsourcing Market by Services (Auditing & Assessment, Consulting, Product Design & Development), End-User (Biotech Companies, Pharmaceutical Companies) - Forecast 2024-2030 - Product Image

Global Biotechnology & Pharmaceutical Services Outsourcing Market by Services (Auditing & Assessment, Consulting, Product Design & Development), End-User (Biotech Companies, Pharmaceutical Companies) - Forecast 2024-2030

  • Report
  • 184 Pages
  • Global
From
Global Pharmaceutical Services Outsourcing Market by Service (Auditing & Assessment, Consulting, Product Design & Development), End-Use (Biotech, Pharma) - Forecast 2024-2030 - Product Image

Global Pharmaceutical Services Outsourcing Market by Service (Auditing & Assessment, Consulting, Product Design & Development), End-Use (Biotech, Pharma) - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Biotechnology / Pharmaceutical Services Outsourcing: Global Strategic Business Report - Product Image

Biotechnology / Pharmaceutical Services Outsourcing: Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Global Pharmaceutical Services Outsourcing Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Pharmaceutical Services Outsourcing Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 195 Pages
  • Global
From
Pharmaceutical Services Outsourcing Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Pharmaceutical Services Outsourcing Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.